SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 285.95 |
| Enterprise Value ($M) | 205.71 |
| Book Value ($M) | 137.25 |
| Book Value / Share | 1.77 |
| Price / Book | 2.08 |
| NCAV ($M) | 105.89 |
| NCAV / Share | 1.37 |
| Price / NCAV | 2.70 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.77 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.59 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.20 |
| Current Ratio | 5.20 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 157.30 |
| Assets | 188.66 |
| Liabilities | 51.42 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -129.73 |
| Net Income | -124.70 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -100.01 |
| Cash from Investing | -16.09 |
| Cash from Financing | 122.44 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Commodore Capital Lp | 7.60 | ||
| 13D/A | Perceptive Advisors Llc | 15.60 | 72.10 | |
| 13D/A | Ra Capital Management, L.p. | |||
| 13D/A | BCLS SB Investco, LP | |||
| 13G/A | Invus Global Management, LLC | 9.40 | 36.38 | |
| 13G/A | Flynn James E | 0.00 | -100.00 | |
| 13G | Vestal Point Capital, LP | 7.30 | ||
| 13G/A | Adage Capital Management, L.P. | 4.55 | ||
| 13G/A | Millennium Management Llc | 2.90 | -44.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| ` UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 178,618 | 684,587 | 26.09 | |
| 342,248 | 1,693,780 | 20.21 | |
| 426,671 | 1,800,386 | 23.70 | |
| 350,649 | 1,826,364 | 19.20 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SANA – Sana Biotechnology, Inc. | SCPH – scPharmaceuticals Inc. |
| SDGR – Schrödinger, Inc. | SLRN – Acelyrin, Inc. |
| SNDX – Syndax Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io